iZafe Group (IZAFE B.ST) Stock Price

iZafe Group Price

OMX·CLOSED
0.30
​
Market closed

Over the last 15 years iZafe Group grew revenue by 63.5% annually, reaching 5.99 M SEK. For iZafe Group, the net margin of -278.4% is up versus -8,207.0% a few years ago.

iZafe Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group business model & stock analysis

iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings.

Frequently asked questions about iZafe Group

Converted at the current exchange rate, the iZafe Group share trades at 0.03 EUR (0.30 SEK).

The iZafe Group share (IZAFE B.ST) is listed on 2 stock exchanges, including: Stockholm (IZAFE B.ST).

The expected revenue of iZafe Group is 37.74 M SEK. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for iZafe Group.

The P/E ratio cannot be calculated for iZafe Group at the moment.

The price-to-sales ratio (P/S) of iZafe Group is currently 2.91. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the iZafe Group stock.

The Eulerpool Quality Score for iZafe Group is 3/10.

The ISIN of iZafe Group is SE0003656834. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of iZafe Group is IZAFE B.ST. The ticker symbol is used to trade iZafe Group shares on the stock exchange.

Fair ValueTerminal
0.25 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
544,636.36 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website izafe.se
Country
Sweden
Currency
SEK
Initial public offering
Apr 4, 2011
ISIN
SE0003656834
Cusip
W5613C106
Market capitalization
109.38 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Se
2.91
EV/EBIT
—
P/B Ratio
9.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-141.95 %
Last updated Oct 24, 2026, 9:33 AM

iZafe Group Peer Group

iZafe Group Ticker

STOCKHOLM · IZAFE-B.STSTOCKHOLM · IZAFE B.ST

iZafe Group FIGI

IZAFEB:SF · BBG001Y25YY8MEDRBSEK:EO · BBG0058M9PH8MEDRBSEK:XH · BBG0058M9PL3MEDRBSEK:XF · BBG0058M9PN1MEDRBSEK:XE · BBG0058M9PQ8MEDRBSEK:XJ · BBG0058M9PR7MEDRBSEK:XL · BBG0058M9PS6MEDRBSEK:XG · BBG0058M9PT5MEDRBSEK:XO · BBG0058M9PV2MEDRBSEK:XS · BBG0058M9PZ8MEDRBSEK:XA · BBG0058M9Q04MEDRBSEK:E1 · BBG0058M9Q13

All fundamentals and in-depth analysis of iZafe Group

Our stock analysis for iZafe Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of iZafe Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.